Epigenetic Biomarkers in Gynecological Cancers Explored
Dr. Lewis Francis, of Swansea University, discusses ChIP methods used in his research on the role of epigenetics in ovarian and endometrial cancers
Dr. Lewis Francis, of Swansea University, discusses ChIP methods used in his research on the role of epigenetics in ovarian and endometrial cancers
Dr. Nobuo Horikoshi explains his research on the epigenetics of DNA repair and how a timely switch of techniques yielded a higher chromatin recovery
Sequencing services provider delighted to be awarded two of the new accolades thanks to its multiple positive reviews
Find out how oncologists are using Droplet Digital PCR to improve the treatment and monitoring of lung cancer patients
Collaboration establishes high-quality sequence map based on Horizon’s GS Knock-Out CHO K1 cell line
SelectScience interviews Dr Laura Lindsey-Boltz, Associate Research Professor in the Nobel Prize-winning Sancar Laboratory, at UNC-Chapel Hill
The next BIG prize drawing is only days away - simply write a laboratory product review today for your chance to win a $400 Amazon voucher or an iPad
New technology has immediate applications in biomanufacturing, diagnostics, cell and gene therapy
Experts from across the globe expected to descend on German capital for two-day workshop series, September 7-8
Extended RAS Panel helps identify colorectal cancer patients eligible for Amgen’s Vectibix
Top rated products now visible at a glance as first Seal of Quality recipients revealed
Fascinating video interviews with leading scientists, a tantalising glimpse into the future for labs and the Scientists' Choice Awards
Thermo Fisher to introduce Ion AmpliSeq™ On-Demand product line of pre-tested gene targets and several other new Ion Torrent NGS offerings at ESHG 2017
New low throughput Sanger sequencing and fragment analysis platform offers trusted technology and workflow with all-in-one cartridge system and cloud connectivity
Discover the science behind the technology and read real, unbiased customer reviews
TwistDx’s proprietary technology, Recombinase Polymerase Amplification (RPA), is transforming the ability to amplify and detect nucleic acids, in laboratory and resource-limited field settings
Learn about new research technologies available and the Life Sciences Scientists’ Choice Awards winners